Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Keiji YAGI"'
Autor:
Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, Shinsuke Otagiri, Kana Yamanashi, Kazunori Nagashima, Reizo Onishi, Keiji Yagisawa, Haruto Nishimura, Takahiro Ito, Atsuo Maemoto, Naoya Sakamoto
Publikováno v:
Intestinal Research, Vol 20, Iss 1, Pp 78-89 (2022)
Background/Aims Inflammatory bowel disease (IBD) patients frequently have zinc deficiency. IBD patients with zinc deficiency have higher risks of IBD-related hospitalization, complications, and requiring surgery. This study aimed to examine the effec
Externí odkaz:
https://doaj.org/article/eb1855429b2f4039ab318c07d09f3ffd
Publikováno v:
SPIE Proceedings.
A new POF fiber/cable will be discussed based on both calculation and measurements, attenuation, intermodal dispersion and material dispersion. Improvements in POF fiber/cable mechanical properties have been achieved without compromising optical tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc56fc1f14cad5f72a9b95c5b13def7
https://doi.org/10.1117/12.141361
https://doi.org/10.1117/12.141361
Autor:
Shinji Okabayashi, Taku Kobayashi, Eiko Saito, Takahiko Toyonaga, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Junichi Tanaka, Keiji Yagisawa, Satoshi Kuronuma, Osamu Takeuchi, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 17, Iss 2, Pp 218-226 (2019)
Background/Aims The pharmacokinetics of tacrolimus (TAC) is known to be largely influenced by single-nucleotide polymorphisms (SNPs) in CYP3A5. Patients starting TAC require careful dose adjustment, owing to the wide range of optimal dosages, dependi
Externí odkaz:
https://doaj.org/article/bc845b68bec44e8eac17faee1ed83e20
Autor:
Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 17, Iss 1, Pp 87-93 (2019)
Background/Aims Oral mesalazine is an important treatment for ulcerative colitis (UC), and non-adherence to mesalazine increases the risk of relapse. Controlled-release (CR) mesalazine has 2 formulations: tablets and granules. The relative acceptabil
Externí odkaz:
https://doaj.org/article/cd43095aa4ee43968684f86ec53bfd8d
Autor:
Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Publikováno v:
Intestinal Research, Vol 18, Iss 3, Pp 343-344 (2020)
Externí odkaz:
https://doaj.org/article/67a71d30520249e1a1445555d38edff2
Autor:
Susumu YUKI, Kazuo KAZIKAWA, Keiji YAGI, Eiji MIYOSHI, Takayasu OKADA, Toyosuke TANOUE, Teruo YUKITOSHI, Kirninari KAWAKAMI, Kohei KAWAI, Hirohiko NOZAKI, Gengo MONMA
Publikováno v:
Tetsu-to-Hagane. 51:2107-2117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::639adabb494f4a45083daea0853a0750
https://doi.org/10.2355/tetsutohagane1955.51.11_2107
https://doi.org/10.2355/tetsutohagane1955.51.11_2107